Stay updated on CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Sign up to get notified when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.

Latest updates to the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new record version (Revision: v3.3.3) was added and an older revision (Revision: v3.3.2) along with the HHS Vulnerability Disclosure link were removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA 2025-11-25 update adds Contacts/Locations and Study Status (Revision: v3.3.2); this also removes the prior 2023-12-27 Revision: v3.3.1.SummaryDifference0.7%

- Check39 days agoChange DetectedRevision history updated: added v3.3.1 and removed v3.2.0 from the Study Record Versions.SummaryDifference0.1%

- Check47 days agoChange DetectedThe history shows removal of the government funding status notice that warned about potential delays and updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check61 days agoChange DetectedRecord History shows several updates, including the addition of IPDSharing in version 3 and subsequent updates to study status and contacts/locations through version 6.SummaryDifference0.1%

- Check90 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference13%

Stay in the know with updates to CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.